Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Neuropace Inc
NPCECurrent price
11.15 USD
+0.045 USD (+0.41%)
Last closed
10.91 USD
Company
www.neuropace.com
ISIN
US6412881053
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
Capitalization
368 467 872 USD
Yield for 12 month
-17.63 %
1Y
3Y
5Y
10Y
15Y
NPCE
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet and patient data management system; and nSight Platform, which facilitates ongoing patient monitoring and streamlines patient support. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California. Address: 455 North Bernardo Avenue, Mountain View, CA, United States, 94043
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
16.86 USDP/E ratio
–Dividend Yield
–Current Year
+79 906 000 USD
Last Year
+65 421 000 USD
Current Quarter
+21 466 000 USD
Last Quarter
+21 060 000 USD
Current Year
+59 085 000 USD
Last Year
+48 122 000 USD
Current Quarter
+16 188 000 USD
Last Quarter
+15 420 000 USD
Key Figures NPCE
1 year
3 years
5 years
10 years
EBITDA
-21 464 000 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-13.39 %
PEG Ratio
–
Return On Equity TTM
-189.35 %
Wall Street Target Price
16.86 USD
Revenue TTM
79 906 000 USD
Book Value
0.27 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
19.20 %
Dividend Yield
–
Gross Profit TTM
59 085 000 USD
Earnings per share
-0.93 USD
Diluted Eps TTM
-0.93 USD
Most Recent Quarter
IV 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-33.97 %
Dividend Analytics NPCE
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History NPCE
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
–
Payout Ratio TTM
–
Last Split Date
–
Stock Valuation NPCE
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
4.87
Price Sales TTM
4.61
Enterprise Value EBITDA
-16.94
Price Book MRQ
45.98
Financials NPCE
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators NPCE
For 52 weeks
5.45 USD
15.11 USD
50 Day MA
11.87 USD
Shares Short Prior Month
308 344
200 Day MA
9.67 USD
Short Ratio
1.92
Shares Short
449 552
Short Percent
2.59 %
BeatStart